KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nov (NOV) Cash & Equivalents (2016 - 2025)

Nov's Cash & Equivalents history spans 17 years, with the latest figure at $1.6 billion for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 26.18% year-over-year to $1.6 billion; the TTM value through Dec 2025 reached $1.6 billion, up 26.18%, while the annual FY2025 figure was $1.6 billion, 26.18% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $1.6 billion at Nov, up from $1.2 billion in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $1.7 billion in Q3 2021 and bottomed at $468.0 million in Q1 2024.
  • The 5-year median for Cash & Equivalents is $1.1 billion (2025), against an average of $1.1 billion.
  • The largest annual shift saw Cash & Equivalents plummeted 51.4% in 2023 before it skyrocketed 147.22% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $1.6 billion in 2021, then plummeted by 32.81% to $1.1 billion in 2022, then dropped by 23.67% to $816.0 million in 2023, then soared by 50.74% to $1.2 billion in 2024, then increased by 26.18% to $1.6 billion in 2025.
  • Per Business Quant, the three most recent readings for NOV's Cash & Equivalents are $1.6 billion (Q4 2025), $1.2 billion (Q3 2025), and $1.1 billion (Q2 2025).